Sartorius Stedim Biotech
(OTC) SDMHF
Sartorius Stedim Biotech Financials at a Glance
Market Cap
$18.78B
Revenue (TTM)
$2.97B
Net Income (TTM)
$265.70M
EPS (TTM)
$3.06
P/E Ratio
63.06
Dividend
$0.76
Beta (Volatility)
0.27 (Low)
Dividend
$0.76
Beta (Volatility)
0.27 (Low)
Price
$193.00
Volume
4,001
Open
$190.30
Price
$193.00
Volume
4,001
Open
$190.30
Previous Close
$193.00
Daily Range
$190.30 - $193.00
52-Week Range
$170.00 - $264.30
Dividend
$0.76
Beta (Volatility)
0.27 (Low)
Price
$193.00
Volume
4,001
Open
$190.30
Previous Close
$193.00
Daily Range
$190.30 - $193.00
52-Week Range
$170.00 - $264.30
SDMHF News
SDMHF: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Sartorius Stedim Biotech
Industry
Life Sciences Tools and Services
Sector
Health CareEmployees
10,265
CEO
René Fáber, PhD
Website
www.sartorius.comHeadquarters
Aubagne, 13781, FR
SDMHF Financials
Key Financial Metrics (TTM)
Gross Margin
45%
Operating Margin
19%
Net Income Margin
9%
Return on Equity
7%
Return on Capital
8%
Return on Assets
3%
Earnings Yield
1.59%
Dividend Yield
0.00%
Payout Ratio
25.26%
Stock Overview
Market Cap
$18.78B
Shares Outstanding
97.30M
Volume
4.00K
Short Interest
0.00%
Avg. Volume
1.51K
Financials (TTM)
Gross Profit
$1.34B
Operating Income
$548.79M
EBITDA
$843.48M
Operating Cash Flow
$538.40M
Capital Expenditure
$393.05M
Free Cash Flow
$145.35M
Cash & ST Invst.
$425.94M
Total Debt
$2.75B
Sartorius Stedim Biotech Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$771.91M
+2.7%
Gross Profit
$316.78M
+0.2%
Gross Margin
41.04%
N/A
Market Cap
$18.78B
N/A
Market Cap/Employee
$1.89M
N/A
Employees
9,961
N/A
Net Income
$47.28M
+3.7%
EBITDA
$771.91M
+481.7%
Quarterly Fundamentals
Net Cash
$2.32B
-6.5%
Accounts Receivable
$227.21M
-14.8%
Inventory
$690.64M
+0.8%
Long Term Debt
$2.17B
-22.7%
Short Term Debt
$580.48M
+798.6%
Return on Assets
3.31%
N/A
Return on Invested Capital
8.31%
N/A
Free Cash Flow
$125.45M
-38.8%
Operating Cash Flow
$242.51M
-14.9%